The Effect of Curcumin on Regression of Liver Fibrosis through Decreased Expression of Transforming Growth Factor-β1 (TGF-β1)

Supriono Supriono, Asri Nugraheni, Handono Kalim, Mudjiwijono Handaru Eko

Abstract


BACKGROUND: Transforming growth factor (TGF)-β1 has a pivotal role in liver fibrogenesis. Curcumin effectively prevent the progression of liver fibrosis through inhibition of TGF-β1/Sma and drosophila MAD (Smad) signaling pathway. However, the role of curcumin in the regression of liver fibrosis is still unknown. This study investigated the role of curcumin and TGF-β1 in liver fibrosis regression.

METHODS: An experimental Wistar rat model included 6 treatment groups as well as positive and negative control groups. The treatment and positive control groups were injected with carbon tetrachlorid (CCl4) for 9 weeks to induce liver fibrosis. After cessation of injection, 3 of the treatment groups were given curcumin and 3 were given carboxymethylcellulose (CMC) for 2, 5 and 9 weeks, while the positive control was untreated. The negative control was injected with normal saline. TGF-β1 liver tissue levels were analyzed by ELISA, while the TGF-β1 expression in liver cells was analyzed by immunohistochemical assay. The metavir score was used to assess the degree of liver fibrosis. Values of p<0.05 were regarded as statistically significant.

RESULTS: Nine weeks of CCl4 injection induced liver fibrosis (metavir F3); and significantly increased TGF-β1 levels and expression in tissues (p=0.00, p=0.021, respectively). Curcumin administration decreased levels and expression of TGF-β1 in the liver and accelerated regression of liver fibrosis. There was a significant correlation between duration of administration of curcumin with an expression of TGF-β1 in the liver tissue (r=0.87; p<0.00).

CONCLUSION: Curcumin accelerates regression of liver fibrosis, likely through decreasing of TGF-β1 expression in the liver.

KEYWORDS: curcumin, TGF-β1, liver fibrosis regression, CCl4, animal model


Full Text:

PDF

References


Ellis EL, Mann DA. Clinical evidence for the regression of liver fibrosis. J Hepatol. 2012; 56: 1171-80, CrossRef.

Breitkopf K, Haas S, Wiercinska E, Singer MV, Dooley S. Anti-TGFbeta strategies for the treatment of chronic liver disease. Alcohol Clin Exp Res. 2005; 29: 121S-31S, CrossRef.

Yoshida K, Murata M, Yamaguchi T, Matsuzaki K. TGF-β/Smad signaling during hepatic fibro-carcinogenesis. Int J Oncol. 2014; 45: 1363-71, CrossRef.

Fabregat I, Moreno-Caceres J, Sanchez A, Dooley S, Dewidar B, Giannelli G, et al. TGF-β signaling and liver disease. FEBS J. 2016; 283: 2219-32, CrossRef.

Xu MY, Hu JJ, Shen J, Wang ML, Zhang QQ, Qu Y, et al. Stat3 signaling activation crosslinking of TGF-β1 in hepatic stellate cell exacerbates liver injury and fibrosis. Biochim Biophys Acta. 2014; 1842: 2237-45, CrossRef.

Wu P, Huang R, Xiong YL, Wu C. Protective effects of curcumin against liver fibrosis through modulating DNA methylation. Chin J Nat Med. 2016; 14: 255-64, CrossRef.

Yao QY, Xu BL, Wang JY, Liu HC, Zhang SC, Tu CT. Inhibition by curcumin of multiple sites of the transforming growth factorbeta1 signaling pathway ameliorates the progression of liver fibrosis induced by carbon tetrachloride in rats. BMC Complement Altern Med. 2012; 12: 156, CrossRef.

Chen N, Geng Q, Zheng J, He S, Huo X, Sun X. Suppression of the TGF-β/Smad signaling pathway and inhibition of hepatic stellate cell proliferation play a role in the hepatoprotective effects of curcumin against alcohol-induced hepatic fibrosis. Int J Mol Med. 2014; 34: 1110-6, CrossRef.

Peng X, Dai C, Liu Q, Li J, Qiu J. Curcumin attenuates on carbon tetrachloride-induced acute liver injury in mice via modulation of the Nrf2/HO-1 and TGF-β1/Smad3 pathway. Molecules. 2018: 23: E215, CrossRef.

Boll M, Weber LWD, Becker E, Stampfl A. Mechanism of carbon tetrachloride-induced hepatotoxicity. Hepatocellular damage by reactive carbon tetrachloride metabolites. Z Naturforsch C. 2001; 56: 649-59, CrossRef.

Scholten D, Trebicka J, Liedtke C, Weiskirchen R. The carbon tetrachloride model in mice. Lab Anim. 2015: 49: 4-11, CrossRef.

Liu Y, Liu H, Meyer C, Li J, Nadalin S, Koenigsrainer A, et al. TGF-β mediated connective tissue growth factor (CTGF) expression in hepatic stellate cells requires Stat3 activation. J Biol Chem. 2013; 288: 30708-19, CrossRef.

Yang L, Roh YS, Song J, Zhang B, Liu C, Loomba R, et al. Transforming growth factor beta signaling in hepatocytes participates in steatohepatitis through regulation of cell death and lipid metabolism in mice. Hepatology. 2014; 59: 483-95, CrossRef.

Yang L, Inokuchi S, Roh YS, Song J, Loomba R, Park EJ, Seki E. Transforming growth factor-β signaling in hepatocytes promotes hepatic fibrosis and carcinogenesis in mice with hepatocytespecific deletion of TAK1. Gastroenterology. 2013; 144: 1042-54.e4, CrossRef.

Kang HC, Nan JX, Park PH, Kim JY, Lee SH, Woo SW, et al. Curcumin inhibits collagen synthesis and hepatic stellate cell activation in-vivo and in-vitro. J Pharm Pharmacol. 2002; 54: 119-26, CrossRef.

Shu JC, He YJ, Lv X, Zhao JR, Zhao J, Shen Y, et al. Effect of curcumin on the proliferation and apoptosis of hepatic stellate cells. Braz J Med Biol Res. 2009; 42: 1173-8, CrossRef.

Dooley S, ten Dijke P. TGF-β in the progression of liver disease. Cell Tissue Res. 2012; 347: 245-56, CrossRef.

Thenappan A, Li Y, Kitisin K, Rashid A, Shetty K, Johnson L, et al. Role of transforming growth factor β signaling and expansion of progenitor cells in regenerating liver. Hepatology. 2010; 51: 1373-82, CrossRef.




DOI: https://doi.org/10.18585/inabj.v11i1.463

Indexed by:

                 

                  

               

     

 

The Prodia Education and Research Institute